Comparing FACIT-fatigue and EORTC QLQ-FA12 for assessing the quality of life in people with cancer-related fatigue.
메타분석
1/5 보강
[PURPOSE OF REVIEW] Two common quality of life (QoL) questionnaires for cancer-related fatigue (CRF) are the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Question
- 연구 설계 systematic review
APA
Zhang B, Randhawa A, et al. (2026). Comparing FACIT-fatigue and EORTC QLQ-FA12 for assessing the quality of life in people with cancer-related fatigue.. Current opinion in supportive and palliative care, 20(1), 52-61. https://doi.org/10.1097/SPC.0000000000000791
MLA
Zhang B, et al.. "Comparing FACIT-fatigue and EORTC QLQ-FA12 for assessing the quality of life in people with cancer-related fatigue.." Current opinion in supportive and palliative care, vol. 20, no. 1, 2026, pp. 52-61.
PMID
41460165
Abstract
[PURPOSE OF REVIEW] Two common quality of life (QoL) questionnaires for cancer-related fatigue (CRF) are the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Fatigue 12 (QLQ-FA12) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue). This systematic review compared their content, validity, and psychometric properties.
[RECENT FINDINGS] Twenty-four studies were included. The QLQ-FA12 (12 items) provides physical, emotional, and cognitive subscales, while the FACIT-Fatigue (13 items) captures self-reported fatigue and its impact on daily function. Both instruments demonstrated validity, internal consistency, test-retest reliability, and sensitivity. Construct validity was supported by correlations with QoL and physical-function measures, and confirmatory factor analyses upheld their intended dimensional structures. The QLQ-FA12's 4-point question format offers distinct domain scores, whereas the FACIT-Fatigue's 5-point statement format yields a single total score. The QLQ-FA12 is preferred when a multidimensional profile is needed, such as in trials addressing specific fatigue drivers or pairing with QLQ-C30 domains. The FACIT-Fatigue suits brief screening or large-scale studies where efficiency and a single total fatigue score are priorities.
[SUMMARY] The EORTC QLQ-FA12 and FACIT-Fatigue are both sufficiently validated for assessing CRF-related QoL. The QLQ-FA12 is more appropriate when a multidimensional profile is required, whereas FACIT-Fatigue suits contexts needing a unidimensional total severity score.
[RECENT FINDINGS] Twenty-four studies were included. The QLQ-FA12 (12 items) provides physical, emotional, and cognitive subscales, while the FACIT-Fatigue (13 items) captures self-reported fatigue and its impact on daily function. Both instruments demonstrated validity, internal consistency, test-retest reliability, and sensitivity. Construct validity was supported by correlations with QoL and physical-function measures, and confirmatory factor analyses upheld their intended dimensional structures. The QLQ-FA12's 4-point question format offers distinct domain scores, whereas the FACIT-Fatigue's 5-point statement format yields a single total score. The QLQ-FA12 is preferred when a multidimensional profile is needed, such as in trials addressing specific fatigue drivers or pairing with QLQ-C30 domains. The FACIT-Fatigue suits brief screening or large-scale studies where efficiency and a single total fatigue score are priorities.
[SUMMARY] The EORTC QLQ-FA12 and FACIT-Fatigue are both sufficiently validated for assessing CRF-related QoL. The QLQ-FA12 is more appropriate when a multidimensional profile is required, whereas FACIT-Fatigue suits contexts needing a unidimensional total severity score.
MeSH Terms
Humans; Quality of Life; Fatigue; Neoplasms; Psychometrics; Surveys and Questionnaires; Reproducibility of Results
같은 제1저자의 인용 많은 논문 (5)
- Deliberately Staged Combined Endovascular Embolization and Subsequent Microsurgery Resection for the Treatment of Cerebral Arteriovenous Malformations.
- Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives.
- A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.
- Sanguinarine Antagonizes NSCLC Through PPARG-Mediated PI3K/AKT Suppression and Autophagic Apoptosis.
- Preoperative lymphocyte-albumin-monocyte index as an inflammation- and nutrition-based predictor of overall survival in triple-negative breast cancer: A retrospective cohort study.